Rondo Therapeutics

Rondo Therapeutics is a clinical-stage biotechnology company based in Hayward, California, developing immune-cell engaging bispecific antibodies designed to treat solid tumors by unleashing the immune system while maximizing efficacy and minimizing side effects. Founded in 2019 by Shelley Force Aldred and Nathan Trinklein, its pipeline includes RNDO-564 (Phase 1 for bladder cancer) plus programs targeting ovarian, endometrial, and renal cancers, backed by a Series A led by Canaan and Red Tree Venture Capital and a collaboration with Eli Lilly. Rondo publishes a corporate and pipeline website but exposes no public developer program, API, or machine-readable API surface; it was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network for enrichment.

Rondo Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Oncology, and Antibodies.

11.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyTherapeuticsOncologyAntibodiesImmunotherapyPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/rondo-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: rondo-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/rondo-therapeutics.png
name: Rondo Therapeutics
description: Rondo Therapeutics is a clinical-stage biotechnology company based in Hayward, California, developing immune-cell
  engaging bispecific antibodies designed to treat solid tumors by unleashing the immune system while maximizing efficacy
  and minimizing side effects. Founded in 2019 by Shelley Force Aldred and Nathan Trinklein, its pipeline includes RNDO-564
  (Phase 1 for bladder cancer) plus programs targeting ovarian, endometrial, and renal cancers, backed by a Series A led by
  Canaan and Red Tree Venture Capital and a collaboration with Eli Lilly. Rondo publishes a corporate and pipeline website
  but exposes no public developer program, API, or machine-readable API surface; it was surfaced as a portfolio company of
  canaan-partners and added to the API Evangelist network for enrichment.
url: https://raw.githubusercontent.com/api-evangelist/rondo-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Therapeutics
- Oncology
- Antibodies
- Immunotherapy
- Pharmaceuticals
apis: []
common:
- type: Website
  url: https://www.rondotx.com
- type: PrivacyPolicy
  url: https://www.rondotx.com/privacy-policy
- type: TermsOfService
  url: https://www.rondotx.com/terms-and-conditions
- type: LinkedIn
  url: https://www.linkedin.com/company/rondotx/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1